JP2020502541A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502541A5
JP2020502541A5 JP2019546767A JP2019546767A JP2020502541A5 JP 2020502541 A5 JP2020502541 A5 JP 2020502541A5 JP 2019546767 A JP2019546767 A JP 2019546767A JP 2019546767 A JP2019546767 A JP 2019546767A JP 2020502541 A5 JP2020502541 A5 JP 2020502541A5
Authority
JP
Japan
Prior art keywords
biomarkers
assay
subject
sjia
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019546767A
Other languages
English (en)
Japanese (ja)
Other versions
JP7132233B2 (ja
JP2020502541A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/061057 external-priority patent/WO2018089764A1/en
Publication of JP2020502541A publication Critical patent/JP2020502541A/ja
Publication of JP2020502541A5 publication Critical patent/JP2020502541A5/ja
Priority to JP2022084414A priority Critical patent/JP2022110148A/ja
Application granted granted Critical
Publication of JP7132233B2 publication Critical patent/JP7132233B2/ja
Priority to JP2024098692A priority patent/JP2024120022A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019546767A 2016-11-11 2017-11-10 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法 Active JP7132233B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022084414A JP2022110148A (ja) 2016-11-11 2022-05-24 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
JP2024098692A JP2024120022A (ja) 2016-11-11 2024-06-19 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662420991P 2016-11-11 2016-11-11
US62/420,991 2016-11-11
PCT/US2017/061057 WO2018089764A1 (en) 2016-11-11 2017-11-10 Compositions and methods for diagnosing and differentiating systemic juvenile idiopathic arthritis and kawasaki disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022084414A Division JP2022110148A (ja) 2016-11-11 2022-05-24 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法

Publications (3)

Publication Number Publication Date
JP2020502541A JP2020502541A (ja) 2020-01-23
JP2020502541A5 true JP2020502541A5 (https=) 2020-10-22
JP7132233B2 JP7132233B2 (ja) 2022-09-06

Family

ID=62110362

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019546767A Active JP7132233B2 (ja) 2016-11-11 2017-11-10 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
JP2022084414A Withdrawn JP2022110148A (ja) 2016-11-11 2022-05-24 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
JP2024098692A Pending JP2024120022A (ja) 2016-11-11 2024-06-19 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022084414A Withdrawn JP2022110148A (ja) 2016-11-11 2022-05-24 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
JP2024098692A Pending JP2024120022A (ja) 2016-11-11 2024-06-19 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法

Country Status (4)

Country Link
US (1) US11448648B2 (https=)
EP (1) EP3529596B1 (https=)
JP (3) JP7132233B2 (https=)
WO (1) WO2018089764A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113252806B (zh) * 2021-03-25 2023-08-29 嘉兴学院 S-腺苷同型半胱氨酸在制备用于诊断或治疗川崎病的产品中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118937A (en) 1989-08-22 1992-06-02 Finnigan Mat Gmbh Process and device for the laser desorption of an analyte molecular ions, especially of biomolecules
US5045694A (en) 1989-09-27 1991-09-03 The Rockefeller University Instrument and method for the laser desorption of ions in mass spectrometry
WO1993003151A1 (en) 1991-08-10 1993-02-18 Medical Research Council Treatment of cell populations
ES2136092T3 (es) 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
ATE199392T1 (de) 1992-12-04 2001-03-15 Medical Res Council Multivalente und multispezifische bindungsproteine, deren herstellung und verwendung
ATE242485T1 (de) 1993-05-28 2003-06-15 Baylor College Medicine Verfahren und massenspektrometer zur desorption und ionisierung von analyten
DE69638321D1 (de) 1995-10-11 2011-03-03 Luminex Corp Gleichzeitige mehrfachanalyse klinischer proben
US5981180A (en) 1995-10-11 1999-11-09 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and methods
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
WO1999019515A1 (en) 1997-10-14 1999-04-22 Luminex Corporation Precision fluorescently dyed particles and methods of making and using same
AU3463699A (en) 1998-04-03 1999-10-25 Phylos, Inc. Addressable protein arrays
US6406921B1 (en) 1998-07-14 2002-06-18 Zyomyx, Incorporated Protein arrays for high-throughput screening
WO2000056934A1 (en) 1999-03-24 2000-09-28 Packard Bioscience Company Continuous porous matrix arrays
WO2009097424A1 (en) 2008-01-29 2009-08-06 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Fstl-1 as a biomarker of inflammation
WO2012019099A2 (en) 2010-08-05 2012-02-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Follistatin-like-protein-1 as a biomarker for inflammatory disorders
US20130052665A1 (en) * 2011-08-25 2013-02-28 Bruce Xuefeng Ling Methods for diagnosis of systemic juvenile idiopathic arthritis
US20140348818A1 (en) 2011-12-29 2014-11-27 Baylor Research Institute Biomarkers of kawasaki disease
WO2013167727A2 (en) 2012-05-11 2013-11-14 Westfaelische Wilhelms-Universitaet Muenster Method for determining arthritis relapse risk

Similar Documents

Publication Publication Date Title
JP6430413B2 (ja) アルツハイマー病の診断のための方法と組成物
CA3052349C (en) Proadm as marker indicating an adverse event
JP2019530875A5 (https=)
JP2022160422A (ja) エキソソームの亜集団の定量および神経変性障害の診断
US20200341011A1 (en) Astrocyte exosome complement-based assay for neuroinflammation in alzheimer's disease and uses thereof
US20140242727A1 (en) Method for diagnosing alzheimer's disease (ad)
JP6415546B2 (ja) 脳卒中の鑑別診断を支援する方法
US20150377905A1 (en) Methods for diagnosis of kawasaki disease
JPWO2022071601A5 (https=)
RU2017115663A (ru) Способы и системы для отличия синдрома раздраженного кишечника от воспалительного заболевания кишечника и глютеновой болезни
EP3497450A1 (en) Histones and/or proadm as markers indicating organ dysfunction
JP2013521490A (ja) 腎臓予後予測アッセイ
CN108474798A (zh) 表征细胞特异性微囊泡的方法
JP2014224759A5 (https=)
JP2020502541A5 (https=)
WO2015174544A1 (ja) 精神疾患判定マーカー
US20250067731A1 (en) Serological assays for parkinson's disease
CN105301229B (zh) Cd146作为分子标记物在诊断、分期或预后神经精神性狼疮中的用途
JPWO2014061456A1 (ja) 統合失調症マーカーセット及びその利用
Joseph et al. Myofibroblast and pro-fibrotic cytokines in fibrosis of IgG4-related disease (IgG4-RD) patients from South Asia: preliminary data
CA3033102C (en) Histones and/or proadm as markers indicating organ dysfunction
EP4427043A1 (en) Use of biomarkers in diagnosing and treating lupus nephritis
JP2020502541A (ja) 全身型若年性特発性関節炎および川崎病を診断および識別するための組成物および方法
US20220349885A1 (en) Biomarker for diagnosing rheumatoid arthritis and uses thereof
JP2019536029A (ja) ヘリコバクター・ピロリ胃炎および萎縮性胃炎と関連リスクの改善された検出方法